The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies (Q73307127)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1999

Language	Label	Description	Also known as
English	The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies	scientific article published on 01 December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

B Movsas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Scott

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W Sause

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Byhardt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Komaki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Cox

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Johnson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Lawton

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A R Dar

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Wasserman

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Roach

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J S Lee

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Andras

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1143-1149

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation therapy oncology group (RTOG) 92-04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-adjusted survival analysis of malignant glioma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: Correlation with survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-utility analysis of a malignant glioma protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Qualms about QALYs.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life: perception of lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Decision analysis in locally advanced non-small-cell lung cancer: is it useful?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900325-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00325-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613306%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73307127&oldid=1832266550"